Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

CpG adjuvant enhances the mucosal immunogenicity and efficacy of a Treponema pallidum DNA vaccine in rabbits.

Zhao F, Liu S, Zhang X, Yu J, Zeng T, Gu W, Cao X, Chen X, Wu Y.

Hum Vaccin Immunother. 2013 Apr;9(4):753-60. doi: 10.4161/hv.23064.

2.

Assessment of the immune responses to Treponema pallidum Gpd DNA vaccine adjuvanted with IL-2 and chitosan nanoparticles before and after Treponema pallidum challenge in rabbits.

Zhao F, Zhang X, Liu S, Zeng T, Yu J, Gu W, Zhang Y, Chen X, Wu Y.

Sci China Life Sci. 2013 Feb;56(2):174-80. doi: 10.1007/s11427-012-4434-4.

PMID:
23334700
3.

Enhanced immune response and protective efficacy of a Treponema pallidum Tp92 DNA vaccine vectored by chitosan nanoparticles and adjuvanted with IL-2.

Zhao F, Wu Y, Zhang X, Yu J, Gu W, Liu S, Zeng T, Zhang Y, Wang S.

Hum Vaccin. 2011 Oct;7(10):1083-9. doi: 10.4161/hv.7.10.16541.

PMID:
21941092
4.

Protective efficacy of a Treponema pallidum Gpd DNA vaccine vectored by chitosan nanoparticles and fused with interleukin-2.

Zhao F, Wang S, Zhang X, Gu W, Yu J, Liu S, Zeng T, Zhang Y, Wu Y.

Can J Microbiol. 2012 Feb;58(2):117-23. doi: 10.1139/w11-115.

PMID:
22260167
5.

Development of a subunit vaccine containing recombinant Riemerella anatipestifer outer membrane protein A and CpG ODN adjuvant.

Chu CY, Liu CH, Liou JJ, Lee JW, Cheng LT.

Vaccine. 2015 Jan 1;33(1):92-9. doi: 10.1016/j.vaccine.2014.11.010.

PMID:
25448104
6.

Safety and efficacy of nasal application of CpG oligodeoxynucleotide as a mucosal adjuvant.

Kodama S, Abe N, Hirano T, Suzuki M.

Laryngoscope. 2006 Feb;116(2):331-5.

PMID:
16467729
7.

[Cloning and expression of outer membrane protein gene Gpd from Treponema pallidum and preliminary studies on its immunogenicity in rabbits].

Zhao FJ, Wu YM, Zhang XH, Liu SQ, Yu MJ.

Wei Sheng Wu Xue Bao. 2005 Oct;45(5):767-71. Chinese.

PMID:
16342773
8.

Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.

Jiang W, Baker HJ, Smith BF.

Infect Immun. 2003 Jan;71(1):40-6.

9.
10.
11.

CpG-oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations.

Van der Stede Y, Verdonck F, Vancaeneghem S, Cox E, Goddeeris BM.

Vet Immunol Immunopathol. 2002 May;86(1-2):31-41.

PMID:
11943328
14.

Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.

Wang X, Zhang X, Kang Y, Jin H, Du X, Zhao G, Yu Y, Li J, Su B, Huang C, Wang B.

Vaccine. 2008 Sep 19;26(40):5135-44. doi: 10.1016/j.vaccine.2008.03.088.

PMID:
18462848
15.

Effects of different CpG oligodeoxynucleotides with inactivated avian H5N1 influenza virus on mucosal immunity of chickens.

Fu J, Liang J, Kang H, Lin J, Yu Q, Yang Q.

Poult Sci. 2013 Nov;92(11):2866-75. doi: 10.3382/ps.2013-03205.

PMID:
24135589
16.
17.

Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants.

Dehghan S, Tafaghodi M, Bolourieh T, Mazaheri V, Torabi A, Abnous K, Tavassoti Kheiri M.

Int J Pharm. 2014 Nov 20;475(1-2):1-8. doi: 10.1016/j.ijpharm.2014.08.032.

PMID:
25148732
18.
19.

Enhancement of mucosal immune responses by intranasal co-delivery of Newcastle disease vaccine plus CpG oligonucleotide in SPF chickens in vivo.

Zhang L, Zhang M, Li J, Cao T, Tian X, Zhou F.

Res Vet Sci. 2008 Dec;85(3):495-502. doi: 10.1016/j.rvsc.2008.02.006.

PMID:
18359498
20.
Items per page

Supplemental Content

Support Center